Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AURO LAB. vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AURO LAB.   ACTAVIS
EQUITY SHARE DATA
    AURO LAB.
Mar-23
ACTAVIS
Dec-18
AURO LAB./
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs11616,146-   
Low Rs5310,831-   
Sales per share (Unadj.) Rs84.93,960.5-  
Earnings per share (Unadj.) Rs3.9-1,275.7-  
Cash flow per share (Unadj.) Rs5.6417.4-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs54.916,335.3-  
Shares outstanding (eoy) m6.23332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.03.4 29.1%   
Avg P/E ratio x21.5-10.6 -203.3%  
P/CF ratio (eoy) x14.932.3 46.2%  
Price / Book Value ratio x1.50.8 185.9%  
Dividend payout %00-   
Avg Mkt Cap Rs m5254,486,134 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m380-   
Avg. sales/employee Rs Th077,944.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,106.1-  
INCOME DATA
Net Sales Rs m5291,317,267 0.0%  
Other income Rs m925,191 0.0%   
Total revenues Rs m5381,342,458 0.0%   
Gross profit Rs m4434,519 0.1%  
Depreciation Rs m11563,103 0.0%   
Interest Rs m876,014 0.0%   
Profit before tax Rs m34-579,407 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,772 0.0%   
Tax Rs m10-7,343 -0.1%   
Profit after tax Rs m24-424,292 -0.0%  
Gross profit margin %8.32.6 316.9%  
Effective tax rate %29.11.3 2,298.3%   
Net profit margin %4.6-32.2 -14.3%  
BALANCE SHEET DATA
Current assets Rs m354540,274 0.1%   
Current liabilities Rs m181477,944 0.0%   
Net working cap to sales %32.64.7 689.0%  
Current ratio x2.01.1 172.6%  
Inventory Days Days220 11.8%  
Debtors Days Days85,59966 129,091.3%  
Net fixed assets Rs m206149,107 0.1%   
Share capital Rs m620-   
"Free" reserves Rs m2800-   
Net worth Rs m3425,433,112 0.0%   
Long term debt Rs m201,913,196 0.0%   
Total assets Rs m5608,493,191 0.0%  
Interest coverage x5.2-6.6 -79.0%   
Debt to equity ratio x0.10.4 16.7%  
Sales to assets ratio x0.90.2 609.1%   
Return on assets %5.8-4.1 -141.8%  
Return on equity %7.1-7.8 -91.4%  
Return on capital %11.8-4.8 -243.0%  
Exports to sales %73.30-   
Imports to sales %47.30-   
Net fx Rs m1350-   
CASH FLOW
From Operations Rs m33470,610 0.0%  
From Investments Rs m-51258,539 -0.0%  
From Financial Activity Rs m-82-807,708 0.0%  
Net Cashflow Rs m-100-78,167 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.44 Rs / USD

Compare AURO LAB. With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare AURO LAB. With: IND SWIFT LA  STRIDES PHARMA SCIENCE  LASA SUPERGENERICS  SHASUN PHARMA  WOCKHARDT  



Today's Market

Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9% Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9%(Closing)

After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.